XML 25 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statement of Comprehensive Income and Changes in Equity (USD $)
In Thousands, unless otherwise specified
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Noncontrolling Interest [Member]
Comprehensive Income [Member]
Total
Balance at at Dec. 31, 2008   $ 10,833 $ 25,238 $ 117,089 $ (27,237) $ 3,952   $ 129,875
Net income 16,220 0 0 16,220 0 1,270 17,490  
Currency translation adjustments   0 0 0 10,497 649 11,146  
Defined Benefit Plans [Abstract]                
Net gain arising during the period, other   0 0 0 3,075 0 3,075  
Amortization of actuarial loss   0 0 0 2,633 0 2,633  
Amortization of prior service cost   0 0 0 65 0 65  
Amortization of initial net asset   0 0 0 (140) 0 (140)  
Current period changes in fair value of derivatives   0 0 0 642 0 642  
Unrealized gain on available-for-sale securities   0 0 0 26 0 26  
Comprehensive income   0 0 0 0 0 34,937 34,937
Comprehensive loss attributable to noncontrolling interest             (1,919)  
Comprehensive income attributable to Quaker Chemical Corporation             33,018  
Dividends Common Stock   0 0 (10,169) 0 0   (10,169)
Dividends paid to noncontrolling interest   0 0 0 0 (890)   (890)
Shares issued upon exercise of stock options and other   10 120 0 0 0   130
Shares issued for empoyee stock purchase plan   26 256 0 0 0   282
Equity-based compensation plans   217 1,913 0 0 0   2,130
Excess tax benefit from stock option exercises 0              
Balance at at Dec. 31, 2009   11,086 27,527 123,140 (10,439) 4,981   156,295
Net income 31,807 0 0 31,807 0 2,284 34,091  
Currency translation adjustments   0 0 0 328 477 805  
Defined Benefit Plans [Abstract]                
Net gain arising during the period, other 0   0 0 (6,267) 0 (6,267)  
Amortization of actuarial loss 0   0 0 1,832 0 1,832  
Amortization of prior service cost   0 0 0 91 0 91  
Amortization of initial net asset   0 0 0 (3) 0 (3)  
Current period changes in fair value of derivatives   0 0 0 708 0 708  
Unrealized gain on available-for-sale securities   0 0 0 14 0 14  
Comprehensive income 0   0 0 0 0 31,271 31,271
Comprehensive loss attributable to noncontrolling interest             (2,761)  
Comprehensive income attributable to Quaker Chemical Corporation             28,510  
Dividends Common Stock   0 0 (10,600) 0 0   (10,600)
Dividends paid to noncontrolling interest   0 0 0 0 (1,021)   (1,021)
Shares issued upon exercise of stock options and other   297 4,965 0 0 0   5,262
Shares issued for empoyee stock purchase plan   10 228 0 0 0   238
Equity-based compensation plans   99 2,997 0 0 0   3,096
Excess tax benefit from stock option exercises 2,558 0 2,558 0 0 0   2,558
Balance at at Dec. 31, 2010 187,099 11,492 38,275 144,347 (13,736) 6,721   187,099
Net income 43,569 0 0 43,569 0 2,331 45,900  
Currency translation adjustments 0   0 0 (8,080) (1,075) (9,155)  
Defined Benefit Plans [Abstract]                
Net gain arising during the period, other   0 0 0 (9,698) 0 (9,698)  
Amortization of actuarial loss   0 0 0 1,230 0 1,230  
Amortization of prior service cost 0       77 0 77  
Current period changes in fair value of derivatives 0       395 0 395  
Unrealized gain on available-for-sale securities   0 0 0 (8) 0 (8)  
Comprehensive income   0 0 0 0 0 28,741 28,741
Comprehensive loss attributable to noncontrolling interest             (1,256)  
Comprehensive income attributable to Quaker Chemical Corporation             27,485  
Dividends Common Stock   0 0 (11,984) 0 0   (11,984)
Dividends paid to noncontrolling interest   0 0 0 0 (1,000)   (1,000)
Stock offering, net of related expenses   1,265 46,878 0 0 0   48,143
Shares issued upon exercise of stock options and other   47 811 0 0 0   858
Shares issued for empoyee stock purchase plan   8 239 0 0 0   247
Equity-based compensation plans   100 3,413 0 0 0   3,513
Excess tax benefit from stock option exercises 109 0 109 0 0 0   109
Balance at at Dec. 31, 2011 $ 255,726 $ 12,912 $ 89,725 $ 175,932 $ (29,820) $ 6,977   $ 255,726